⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1403442 | 0.62 | — | — | |
| SCHEMBL3239523 | 0.53 | — | — | |
| SCHEMBL388722 | 0.53 | — | — | |
| SCHEMBL11331916 | 0.50 | — | — | |
| SCHEMBL22296900 | 0.50 | — | — | |
| SCHEMBL6765508 | 0.39 | — | — | |
| SCHEMBL239887 | 0.39 | — | — | |
| SCHEMBL9738500 | 0.37 | — | — | |
| SCHEMBL1203 | 0.37 | — | — | |
| SCHEMBL11730161 | 0.37 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8853132-B2 | Directed synthesis of oligophosphoramidate stereoisomers | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2014-10-07 | — | — | US | claimed |
| US-20140045719-A1 | DIRECTED SYNTHESIS OF OLIGOPHOSPHORAMIDATE STEREOISOMERS | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2014-02-13 | — | — | US | claimed |
| US-8569515-B2 | Directed synthesis of oligophosphoramidate stereoisomers | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2013-10-29 | — | — | US | claimed |
| EP-2370450-A1 | DIRECTED SYNTHESIS OF OLIGOPHOSPHORAMIDATE STEREOISOMERS | Roche Diagnostics GmbH (DE) | 2011-10-05 | — | — | EP | claimed |
| US-20110212861-A1 | DIRECTED SYNTHESIS OF OLIGOPHOSPHORAMIDATE STEREOISOMERS | ROCHE DIAGNOSTICS GMBH (DE) | 2011-09-01 | — | — | US | claimed |
| WO-2010060599-A1 | DIRECTED SYNTHESIS OF OLIGOPHOSPHORAMIDATE STEREOISOMERS | ROCHE DIAGNOSTICS GMBH (DE) | 2010-06-03 | — | — | WO | claimed |
| US-8853132-B2 | Directed synthesis of oligophosphoramidate stereoisomers | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2014-10-07 | — | — | US | disclosed |
| US-20140045719-A1 | DIRECTED SYNTHESIS OF OLIGOPHOSPHORAMIDATE STEREOISOMERS | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| US-8569515-B2 | Directed synthesis of oligophosphoramidate stereoisomers | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| EP-2370450-A1 | DIRECTED SYNTHESIS OF OLIGOPHOSPHORAMIDATE STEREOISOMERS | Roche Diagnostics GmbH (DE) | 2011-10-05 | — | — | EP | disclosed |
| US-20110212861-A1 | DIRECTED SYNTHESIS OF OLIGOPHOSPHORAMIDATE STEREOISOMERS | ROCHE DIAGNOSTICS GMBH (DE) | 2011-09-01 | — | — | US | disclosed |
| WO-2010060599-A1 | DIRECTED SYNTHESIS OF OLIGOPHOSPHORAMIDATE STEREOISOMERS | ROCHE DIAGNOSTICS GMBH (DE) | 2010-06-03 | — | — | WO | disclosed |